• Je něco špatně v tomto záznamu ?

Extracorporeal shock wave therapy for treatment of vulvodynia: a prospective, randomized, double-blind, placebo-controlled study

K. Hurt, F. Zahalka, M. Halaska, I. Rakovicova, A. Krajcova,

. 2020 ; 56 (2) : 169-174. [pub] 20200114

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028310

BACKGROUND: Currently, there are no effective therapy strategies for idiopathic, non-organic vulvodynia in women. ESWT (extracorporeal shock wave therapy) is a nonsurgical/noninvasive technique widely used to treat musculoskeletal diseases, muscle spasticity and hypertonia, renal and biliary calculi and urological disorders. AIM: We examined the effects of ESWT on vulvodynia in women. DESIGN: A prospective, randomized, double-blind, placebo-controlled study was conducted between 2015 and 2018 following a feasibility study. SETTING: Obstetrics and Gynecology Hospital departments. POPULATION: The study included 62 women with vulvodynia for at least 3 months. METHODS: The women were randomly assigned to either a treatment group (N.=31) or a placebo group (N.=31). The patients in the treatment group received perineally applied ESWT weekly (3000 pulses each for four consecutive weeks). The energy flux density was 0.25 mJ/mm2, frequency 4 Hz, focus zone 0-30 mm, therapeutic efficacy 0-90 mm, stand-off II. The device used was a standard electromagnetic shock wave unit with a focused shock wave handpiece. The position of the shock wave transducer was changed six times after every 500 pulses. Patients in the placebo group underwent the same treatment procedure, but the handpiece was provided with a placebo stand-off that disabled energy transmission. Subjective pain was self-evaluated by each patient using two tools before and after treatment: a 10 cm linear visual analogue scale (VAS, 0-10) and a cotton-swab test (CST, Goetsch scale 0-4). Follow-ups were done 1, 4, and 12 weeks post-ESWT. RESULTS: In all, 61 women completed the study. We tested for differences in the VAS and CST within and between the treatment and placebo groups. The testing was between before treatment and particular follow-up. We found significant changes in the treatment group. Reductions in VAS (P<0.01) and CST (P<0.01) were observed at all three follow-ups. At all assessments, pain reduction was always >30%. In the placebo group there were no statistically significant changes between before and after treatment. There were no differences between the treatment and placebo groups before treatment but statistically significant differences at all three follow-ups (VAS P<0.01); CST P<0.01). CONCLUSIONS: ESWT seems to reduce pain perception in our treatment group. Thus, we are encouraged to explore this technique further. CLINICAL REHABILITATION IMPACT: The method is easily replicable, inexpensive, and without known side effects.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028310
003      
CZ-PrNML
005      
20210114153505.0
007      
ta
008      
210105s2020 it f 000 0|eng||
009      
AR
024    7_
$a 10.23736/S1973-9087.20.05903-1 $2 doi
035    __
$a (PubMed)31939265
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Hurt, Karel $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, Prague, Czech Republic - hurt@infoprague.com.
245    10
$a Extracorporeal shock wave therapy for treatment of vulvodynia: a prospective, randomized, double-blind, placebo-controlled study / $c K. Hurt, F. Zahalka, M. Halaska, I. Rakovicova, A. Krajcova,
520    9_
$a BACKGROUND: Currently, there are no effective therapy strategies for idiopathic, non-organic vulvodynia in women. ESWT (extracorporeal shock wave therapy) is a nonsurgical/noninvasive technique widely used to treat musculoskeletal diseases, muscle spasticity and hypertonia, renal and biliary calculi and urological disorders. AIM: We examined the effects of ESWT on vulvodynia in women. DESIGN: A prospective, randomized, double-blind, placebo-controlled study was conducted between 2015 and 2018 following a feasibility study. SETTING: Obstetrics and Gynecology Hospital departments. POPULATION: The study included 62 women with vulvodynia for at least 3 months. METHODS: The women were randomly assigned to either a treatment group (N.=31) or a placebo group (N.=31). The patients in the treatment group received perineally applied ESWT weekly (3000 pulses each for four consecutive weeks). The energy flux density was 0.25 mJ/mm2, frequency 4 Hz, focus zone 0-30 mm, therapeutic efficacy 0-90 mm, stand-off II. The device used was a standard electromagnetic shock wave unit with a focused shock wave handpiece. The position of the shock wave transducer was changed six times after every 500 pulses. Patients in the placebo group underwent the same treatment procedure, but the handpiece was provided with a placebo stand-off that disabled energy transmission. Subjective pain was self-evaluated by each patient using two tools before and after treatment: a 10 cm linear visual analogue scale (VAS, 0-10) and a cotton-swab test (CST, Goetsch scale 0-4). Follow-ups were done 1, 4, and 12 weeks post-ESWT. RESULTS: In all, 61 women completed the study. We tested for differences in the VAS and CST within and between the treatment and placebo groups. The testing was between before treatment and particular follow-up. We found significant changes in the treatment group. Reductions in VAS (P<0.01) and CST (P<0.01) were observed at all three follow-ups. At all assessments, pain reduction was always >30%. In the placebo group there were no statistically significant changes between before and after treatment. There were no differences between the treatment and placebo groups before treatment but statistically significant differences at all three follow-ups (VAS P<0.01); CST P<0.01). CONCLUSIONS: ESWT seems to reduce pain perception in our treatment group. Thus, we are encouraged to explore this technique further. CLINICAL REHABILITATION IMPACT: The method is easily replicable, inexpensive, and without known side effects.
650    _2
$a dospělí $7 D000328
650    _2
$a dvojitá slepá metoda $7 D004311
650    12
$a léčba mimotělní rázovou vlnou $7 D000074059
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a měření bolesti $7 D010147
650    _2
$a prospektivní studie $7 D011446
650    _2
$a vulvodynie $x terapie $7 D056650
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Zahalka, Frantisek $u Sports Motoric Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
700    1_
$a Halaska, Michael $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Rakovicova, Ivana $u OBGYN Department Amedeana Prague, Prague, Czech Republic.
700    1_
$a Krajcova, Aneta $u Department of Plastic Surgery, First Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00174347 $t European journal of physical and rehabilitation medicine $x 1973-9095 $g Roč. 56, č. 2 (2020), s. 169-174
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31939265 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114153502 $b ABA008
999    __
$a ok $b bmc $g 1608645 $s 1119490
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 56 $c 2 $d 169-174 $e 20200114 $i 1973-9095 $m European Journal of Physical and Rehabilitation Medicine $n Eur. j. phys. rehabil. med. $x MED00174347
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace